Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 158
Filter
1.
J Physiol Pharmacol ; 69(3)2018 Jun.
Article in English | MEDLINE | ID: mdl-30279307

ABSTRACT

Turmeric is a yellowish orange spice, widely used in Asian cuisine and obtained from the rhizome of Curcuma longa. It is a mixture of three curcuminoids namely, curcumin, demethoxycurcumin and bisdemethoxycurcumin. Turmeric has been used as a medicinal substance since ancient times for respiratory and gastrointestinal problems. The aim of the present study was to investigate which curcuminoid contributes to the observed pharmacological activities, all three curcuminoids, the major curcumin metabolite tetrahydrocurcumin, and the non-enzymatic curcumin hydrolysis products ferulic acid, feruloyl methane and vanillin were analyzed for spasmolytic, inotropic and chronotropic activity. Furthermore, their uptake in respective tissue samples was also investigated and correlated with activity. Spasmolytic activity was determined in guinea pig ileum, aorta and pulmonary artery. Inotropic and chronotropic activity was determined on guinea pig papillary muscles and right atrium respectively, while tissue uptake was quantified by using high-performance liquid chromatography (HPLC). All the curcuminoids exhibited significant spasmolytic activity with highest EC50 values for bisdemethoxycurcumin (5.8 ± 0.6 µM) followed by curcumin (12.9 ± 0.7 µM), demethoxycurcumin (16.8 ± 3 µM) and tetrahydrocurcumin (22.9 ± 1.5 µM). While only demethoxycurcumin was able to significantly relax the pulmonary artery with EC50 value of 15.78 ± 0.85 µM. All three curcuminoids showed mild negative chronotropic effects in the isolated right atrium; tetrahydrocurcumin demonstrated no activity. Curcumin and bisdemethoxycurcumin also showed mild positive inotropic effect whereas demethoxycurcumin and tetrahydrocurcumin exhibited weak negative inotropic one. Interestingly, ferulic acid, feruloyl methane and vanillin demonstrated no pharmacologicical activity at all in the various isolated organs. All three curcuminoids and tetrahydrocurcumin showed high uptake into the various tissues where concentrations correlated with pharmacological activity. The results indicate pronounced differences in the in vitro pharmacological activities of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin which have to be considered in humans after per-oral intake of turmeric powder.


Subject(s)
Cardiotonic Agents/pharmacology , Curcumin/analogs & derivatives , Curcumin/pharmacology , Parasympatholytics/pharmacology , Vasodilator Agents/pharmacology , Animals , Aorta/drug effects , Aorta/physiology , Atrial Function/drug effects , Curcuma , Female , Guinea Pigs , Heart Atria/drug effects , Heart Rate/drug effects , Ileum/drug effects , Ileum/physiology , In Vitro Techniques , Male , Papillary Muscles/drug effects , Papillary Muscles/physiology , Pulmonary Artery/drug effects , Pulmonary Artery/physiology
2.
World J Urol ; 35(6): 913-919, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27734132

ABSTRACT

PURPOSE: To evaluate stool habits and associated quality of life (QoL) in a matched pair analysis of patients who underwent continent cutaneous diversion using the ileocecal segment [Mainz pouch I (MzPI)] with an intussuscepted ileal nipple as efferent segment with those receiving an ileal conduit (IC) after radical cystectomy. METHODS: We identified 250 patients who underwent radical cystectomy and urinary diversion (UD) with either MzPI with an ileal nipple or IC in our database. A detailed history of stool habits using the modified Wexner score was obtained, and questions addressing general lifestyle, comparison of symptom differences before and after surgery considering bowel function as well as bowel-associated QoL were assessed. RESULTS: Forty-five age- and sex-matched pairs could be compared. Overall, stool incontinence (p = 0.481) and the Wexner score (p = 0.464) revealed no differences between both groups. However, patients with MzPI as compared to those with IC had significant higher rates of stool frequency (53 vs 31 %), softer stool consistencies (60 vs 13 %), diarrhea (62 vs 20 %) and a lower rate of constipation (4 vs 22 %). Patients with MzPI had a trend toward lower bowel-associated QoL compared with patients with IC. Similarly, the MzPI group reported a significantly impaired overall postoperative QoL (51 %) compared to the IC group (29 %) (p = 0.024). CONCLUSIONS: Patients following UD by MzPI have an increased stool frequency and softer stool consistency. However, there is no difference between both groups in terms of de novo stool incontinence. Change in bowel habits should be part of preoperative informed consent in any kind of UD. Careful patient selection is of paramount importance.


Subject(s)
Quality of Life , Urinary Bladder Neoplasms/surgery , Urinary Diversion/methods , Urinary Diversion/psychology , Urinary Reservoirs, Continent , Adult , Aged , Case-Control Studies , Constipation/epidemiology , Constipation/physiopathology , Cystectomy/adverse effects , Cystectomy/methods , Fecal Incontinence/epidemiology , Fecal Incontinence/physiopathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Risk Assessment , Surveys and Questionnaires , Treatment Outcome , Urinary Bladder Neoplasms/pathology
3.
Antimicrob Agents Chemother ; 57(7): 2996-3002, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23587954

ABSTRACT

The use of cardiopulmonary bypass (CPB) during cardiac surgery causes regional ventilation-perfusion mismatch, contributing to regional disturbances in antibiotic penetration into lung tissue. Ventilation-perfusion mismatch is associated with postoperative pneumonia, a frequent and devastating complication after cardiac surgery. In this prospective clinical animal study, we performed in vivo microdialysis to determine the effect of CPB on regional penetration of levofloxacin (LVX) into lung tissue. Six pigs underwent surgery with CPB (CPB group), and another six pigs underwent surgery without CPB (off-pump coronary artery bypass grafting; OPCAB group). LVX (750 mg) was administered intravenously to all pigs immediately after surgery. For regional measurements of LVX in pulmonary concentrations, microdialysis probes were inserted in both lungs of each pig. Pigs were placed in the right lateral position. Time versus concentration profiles of unbound LVX were measured in the upper and lower lung tissue and plasma in all pigs. In all pigs, maximum concentrations (Cmax) of LVX were significantly lower in the upper lung than in the lower lung (OPCAB, P = 0.035; CPB, P < 0.001). Median Cmax of LVX showed a significant difference in the upper versus lower lung in the CPB group (P < 0.05). No significant difference was found in the median Cmax of LVX in the upper and the lower lung in the OPCAB group (P = 0.32). Our data indicate that CPB affects perioperative regional antibiotic penetration into lung tissue. Common clinical antibiotic dosing schemes should be reevaluated in patients undergoing coronary artery bypass grafting with CPB.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Cardiopulmonary Bypass , Levofloxacin/pharmacokinetics , Lung/metabolism , Animals , Anti-Bacterial Agents/analysis , Female , Levofloxacin/analysis , Lung/blood supply , Lung/drug effects , Male , Microdialysis , Swine
4.
Br J Pharmacol ; 168(7): 1662-74, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23170857

ABSTRACT

BACKGROUND AND PURPOSE: The C-X-C chemokine receptors 3 (CXCR3) and C-X-C chemokine receptors 4 (CXCR4) are involved in various autoimmune diseases and cancers. Small antagonists have previously been shown to cross-inhibit chemokine binding to CXCR4, CC chemokine receptors 2 (CCR2) and 5 (CCR5) heteromers. We investigated whether CXCR3 and CXCR4 can form heteromeric complexes and the binding characteristics of chemokines and small ligand compounds to these chemokine receptor heteromers. EXPERIMENTAL APPROACH: CXCR3-CXCR4 heteromers were identified in HEK293T cells using co-immunoprecipitation, time-resolved fluorescence resonance energy transfer, saturation BRET and the GPCR-heteromer identification technology (HIT) approach. Equilibrium competition binding and dissociation experiments were performed to detect negative binding cooperativity. KEY RESULTS: We provide evidence that chemokine receptors CXCR3 and CXCR4 form heteromeric complexes in HEK293T cells. Chemokine binding was mutually exclusive on membranes co-expressing CXCR3 and CXCR4 as revealed by equilibrium competition binding and dissociation experiments. The small CXCR3 agonist VUF10661 impaired binding of CXCL12 to CXCR4, whereas small antagonists were unable to cross-inhibit chemokine binding to the other chemokine receptor. In contrast, negative binding cooperativity between CXCR3 and CXCR4 chemokines was not observed in intact cells. However, using the GPCR-HIT approach, we have evidence for specific ß-arrestin2 recruitment to CXCR3-CXCR4 heteromers in response to agonist stimulation. CONCLUSIONS AND IMPLICATIONS: This study indicates that heteromeric CXCR3-CXCR4 complexes may act as functional units in living cells, which potentially open up novel therapeutic opportunities.


Subject(s)
Receptors, CXCR3/metabolism , Receptors, CXCR4/metabolism , Arrestins/metabolism , Cell Membrane/metabolism , Chemokine CXCL10/metabolism , Chemokine CXCL12/metabolism , Fluorescence Resonance Energy Transfer , HEK293 Cells , Humans , Immunoprecipitation , Ligands , Protein Binding , Protein Multimerization , Radioligand Assay , Receptors, CXCR3/agonists , Receptors, CXCR4/agonists , Signal Transduction , beta-Arrestins
5.
Br J Anaesth ; 109(5): 790-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22831890

ABSTRACT

BACKGROUND: Arterial catheterization is painful and is associated with patient stress and anxiety. Analgesia is usually provided by subcutaneous injection of local anaesthetic. An alternative is topical anaesthesia, such as Rapydan which is a novel topical anaesthetic patch containing 70 mg each of lidocaine and tetracaine. We therefore tested the hypothesis that Rapydan patch analgesia is non-inferior to subcutaneous local anaesthetic. METHODS: Ninety patients undergoing elective major cardiac surgery were included in this prospective, double-blind clinical trial. Patients were randomly assigned to receive either a lidocaine/tetracaine patch, followed by subcutaneous injection 0.5 ml of normal saline solution, or placebo patch with subsequent subcutaneous injection of 0.5 ml of lidocaine 1%. Pain during arterial catheterization using 100-mm-long visual analogue scale (VAS) was the primary outcome. Other outcomes were pain during anaesthetic/saline injection and plasma tetracaine concentrations. RESULTS: VAS pain scores during arterial puncture were comparable in both groups and Rapydan was non-inferior to subcutaneous lidocaine. Pain scores at the time of subcutaneous injection were significantly lower (better) in patients assigned to the lidocaine/tetracaine patch than to lidocaine (P=0.001). Plasma tetracaine concentrations never exceeded the detection limit of 25 ng ml(-1) at any time in any patient. CONCLUSIONS: Both the lidocaine/tetracaine patch and subcutaneous injection of lidocaine provided comparable pain control during arterial catheter insertion. Subcutaneous lidocaine caused discomfort during injection, whereas the lidocaine/tetracaine patch required placement 20 min before the procedure. Given adequate time, the patch provided better overall analgesia by obviating the need for subcutaneous infiltration.


Subject(s)
Anesthetics, Local/administration & dosage , Catheterization, Central Venous/adverse effects , Lidocaine/administration & dosage , Pain/prevention & control , Tetracaine/administration & dosage , Transdermal Patch , Administration, Cutaneous , Adolescent , Adult , Aged , Aged, 80 and over , Anesthesia, Local/methods , Double-Blind Method , Drug Combinations , Female , Humans , Male , Middle Aged , Pain/etiology , Prospective Studies , Young Adult
7.
Science ; 317(5845): 1706-9, 2007 Sep 21.
Article in English | MEDLINE | ID: mdl-17885125

ABSTRACT

Water has supposedly marked the surface of Mars and produced characteristic landforms. To understand the history of water on Mars, we take a close look at key locations with the High-Resolution Imaging Science Experiment on board the Mars Reconnaissance Orbiter, reaching fine spatial scales of 25 to 32 centimeters per pixel. Boulders ranging up to approximately 2 meters in diameter are ubiquitous in the middle to high latitudes, which include deposits previously interpreted as finegrained ocean sediments or dusty snow. Bright gully deposits identify six locations with very recent activity, but these lie on steep (20 degrees to 35 degrees) slopes where dry mass wasting could occur. Thus, we cannot confirm the reality of ancient oceans or water in active gullies but do see evidence of fluvial modification of geologically recent mid-latitude gullies and equatorial impact craters.


Subject(s)
Mars , Water , Extraterrestrial Environment , Geological Phenomena , Geology
8.
Science ; 317(5845): 1709-11, 2007 Sep 21.
Article in English | MEDLINE | ID: mdl-17885126

ABSTRACT

Athabasca Valles is a young outflow channel system on Mars that may have been carved by catastrophic water floods. However, images acquired by the High-Resolution Imaging Science Experiment camera onboard the Mars Reconnaissance Orbiter spacecraft reveal that Athabasca Valles is now entirely draped by a thin layer of solidified lava-the remnant of a once-swollen river of molten rock. The lava erupted from a fissure, inundated the channels, and drained downstream in geologically recent times. Purported ice features in Athabasca Valles and its distal basin, Cerberus Palus, are actually composed of this lava. Similar volcanic processes may have operated in other ostensibly fluvial channels, which could explain in part why the landers sent to investigate sites of ancient flooding on Mars have predominantly found lava at the surface instead.


Subject(s)
Mars , Water , Extraterrestrial Environment , Geological Phenomena , Geology
9.
J Phys Chem B ; 111(29): 8649-54, 2007 Jul 26.
Article in English | MEDLINE | ID: mdl-17608514

ABSTRACT

The flocculation behaviors of three series of polycations with narrow molecular weight distributions carrying hydrophobic substituents on their backbones [poly(N-vinylbenzyl-N,N,N-trimethylammonium chloride), poly(N-vinylbenzyl-N,N-dimethyl-N-butylammonium chloride), and poly(N-vinylbenzylpyridinium chloride)] were investigated in dispersions of monodisperse polystyrene latexes and kaolin. Apparently, the charge density of the polycations decreases with increasing substituent hydrophobicity and increasing molecular weight of the polyelectrolytes. The necessary amount of flocculant for phase separation in dispersions with high substrate surface charge densities increases with increasing hydrophobicity of the polyelectrolyte. Nevertheless, the introduction of hydrophobic functionalities is beneficial, resulting in a substantial broadening of the range between the minimum and maximum amounts of flocculant necessary for efficient flocculation (flocculation window). An increase in ionic strength supports this effect. When the substrate has a low charge density, the hydrophobic interactions play a much more significant role in the flocculation process. Here, the minimum efficient doses remained the same for all three polyelectrolytes investigated, but the width of the flocculation window increased as the polycation hydrophobicity and the molecular weight increased. The necessary amount of flocculant increased with an increase in particle size at constant solid content of the dispersion, as well as with a decreasing number of particles at a constant particle size.

10.
J Phys Chem B ; 111(29): 8572-81, 2007 Jul 26.
Article in English | MEDLINE | ID: mdl-17461569

ABSTRACT

In this work, the lateral mobility of polyelectrolyte multilayers was investigated by means of the fluorescence recovery after photobleaching (FRAP) technique, with special attention to the effect of relevant parameters during and after preparation. Different polyelectrolytes with respect to charge density, stiffness, and hydrophilicity were compared. From the experimental results emerged that the density of charged sites along the polymer is the most important parameter controlling the formation of polymer complexes. At higher charge density, more complexes are formed, and the diffusion coefficient decreases. It was observed that the intrinsic backbone stiffness reduces the interpenetration of polyelectrolyte layers and the formation of complexes promoting the lateral mobility. In addition, the lateral mobility increases with increasing ionic strength and with decreasing hydration shell of the added anion in the polyelectrolyte solution. The effect of heating or annealing in electrolyte solution after preparation was also investigated along with the embedding of the probing layer at controlled distances to the multilayer surface.

11.
Nucleosides Nucleotides Nucleic Acids ; 25(9-11): 1013-7, 2006.
Article in English | MEDLINE | ID: mdl-17065056

ABSTRACT

Resveratrol (3,4',5-trihydroxystilbene, RV) exerts remarkable cytostatic and cytotoxic effects against a multitude of human cancer cell lines. Since the introduction of additional hydroxyl groups was supposed to increase the biological activity of RV, we have synthesized a number of polyhydroxylated stilbene analogues as potential antitumor agents. In this study, the activity of 3,3',4,4',5,5'-hexahydroxystilbene (M8) was investigated in HL-60 human promyelocytic leukemia cells. Employing a growth inhibition assay, incubation with M8 and RV resulted in IC50 values of 6.25 and 12 microM, respectively. Using a specific Hoechst/propidium iodide double staining method, we found that M8 was able to induce apoptosis in concentrations significantly lower than those of RV. In addition, M8 arrested cells in the S phase and totally depleted cells in the G2-M phase of the cell cycle (143% and 0% of control after treatment with 12.5 microM M8, respectively). We therefore believe that this promising agent deserves further preclinical and in vivo testing.


Subject(s)
Antineoplastic Agents/pharmacology , Drug Screening Assays, Antitumor , Leukemia, Promyelocytic, Acute/drug therapy , Pyrogallol/analogs & derivatives , Stilbenes/pharmacology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bisbenzimidazole/pharmacology , Cell Cycle/drug effects , Cytarabine/administration & dosage , Dose-Response Relationship, Drug , Drug Synergism , Fluorescent Dyes/pharmacology , HL-60 Cells , Humans , Inhibitory Concentration 50 , Propidium/pharmacology , Pyrogallol/pharmacology
12.
Nucleosides Nucleotides Nucleic Acids ; 25(9-11): 1019-24, 2006.
Article in English | MEDLINE | ID: mdl-17065057

ABSTRACT

Resveratrol (RV), a naturally occurring stilbene derivative, is a potent free radical scavenger causing a number of biochemical and antineoplastic effects. It was shown to induce differentiation and apoptosis in leukemia cells and was also identified as an inhibitor of ribonucleotide reductase (RR), a key enzyme of DNA synthesis. In this study, we report about the biochemical effects of RV in HL-60 human promyelocytic leukemia cells. RV effectively inhibited in situ RR activity. Furthermore, incubation of HL-60 cells with RV significantly decreased intracellular dCTP, dTTP, dATP and dGTP concentrations. In growth inhibition and clonogenic assays, RV acted synergistically with both Ara-C and tiazofurin in HL-60 cells. We conclude that RV could become a viable candidate as one compound in the combination chemotherapy of leukemia and therefore deserves further in vitro and in vivo testing.


Subject(s)
Cytarabine/administration & dosage , Drug Synergism , Leukemia, Promyelocytic, Acute/drug therapy , Ribavirin/analogs & derivatives , Stilbenes/administration & dosage , Antimetabolites, Antineoplastic/administration & dosage , Antineoplastic Agents, Phytogenic/administration & dosage , Apoptosis , Cell Proliferation/drug effects , Drug Screening Assays, Antitumor , Free Radical Scavengers , Free Radicals , HL-60 Cells , Humans , Resveratrol , Ribavirin/administration & dosage
13.
Biomacromolecules ; 6(3): 1573-85, 2005.
Article in English | MEDLINE | ID: mdl-15877380

ABSTRACT

Bovine serum albumin (BSA) and poly(diallyldimethylammonium chloride) (PDADMAC) spontaneously form, over a range of ionic strength I and pH, dense fluids rich in both macroions. To study their nanostructure, these coacervates were prepared at low I and high pH (strong interaction) or at high I and lower pH (weaker interaction), with polymer MWs ranging from 90K to 700K, and then examined by dynamic light scattering (DLS) and rheology. DLS shows a dominant and surprisingly fast protein diffusional mode independent of polymer MW; accompanied by robust slow modes, slower by 1-2 orders of magnitude, which are also insensitive to MW and are present regardless of I, pH, and sample aging. High MW sensitivity was observed by rheology for the terminal time (order of milliseconds), which increased as well with the strength of polyelectrolyte-protein interaction. Viscoelastic behavior also indicated a tenuous network, solidlike at low strain but re-forming after breakage by shear. Two models, both of which have strengths and defects, are put forward: (I) macroion-rich domains dispersed in a continuum of macroion-poor domains near the percolation limit and (II) a semidilute solution of PDADMAC chains with interchain friction modulated by transient BSA-PDADMAC association.


Subject(s)
Models, Biological , Polyethylenes/metabolism , Polymers/metabolism , Quaternary Ammonium Compounds/metabolism , Serum Albumin, Bovine/metabolism , Animals , Cattle , Electrolytes , Polyethylenes/analysis , Polymers/analysis , Protein Binding/physiology , Quaternary Ammonium Compounds/analysis , Serum Albumin, Bovine/analysis
14.
Xenobiotica ; 35(12): 1101-19, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16418064

ABSTRACT

Sulfation of resveratrol, a polyphenolic compound present in grapes and wine with anticancer and cardioprotective activities, was studied in human liver cytosol. In the presence of 3'-phosphoadenosine-5'-phosphosulfate, three metabolites (M1-3) whose structures were identified by mass spectrometry and NMR as trans-resveratrol-3-O-sulfate, trans-resveratrol-4'-O-sulfate, and trans-resveratrol-3-O-4'-O-disulfate, respectively. The kinetics of M1 formation in human liver cytosol exhibited an pattern of substrate inhibition with a K(i) of 21.3 +/- 8.73 microM and a V(max)/K(m) of 1.63 +/- 0.41 microLmin(-1)mg(-1) protein. Formation of M2 and M3 showed sigmoidal kinetics with about 56-fold higher V(max)/K(m) values for M3 than for M2 (2.23 +/- 0.14 and 0.04 +/- 0.01 microLmin(-1)mg(-1)). Incubation in the presence of human recombinant sulfotransferases (SULTs) demonstrated that M1 is almost exclusively catalysed by SULT1A1 and only to a minor extent by SULT 1A2, 1A3 and 1E1, whereas M2 is selectively formed by SULT1A2. M3 is mainly catalysed by SULT1A2 and 1A3. In conclusion, the results elucidate the enzymatic pathways of resveratrol in human liver, which must be considered in humans following oral uptake of dietary resveratrol.


Subject(s)
Arylsulfotransferase/metabolism , Liver/enzymology , Stilbenes/metabolism , Sulfotransferases/metabolism , Adolescent , Adult , Aged , Chromatography, Liquid , Cytosol/enzymology , Dose-Response Relationship, Drug , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Female , Humans , Kinetics , Magnetic Resonance Spectroscopy , Male , Mass Spectrometry , Middle Aged , Protein Isoforms/metabolism , Recombinant Proteins/metabolism , Resveratrol , Sulfates/chemistry , Sulfates/metabolism , Sulfotransferases/chemistry
15.
Eur J Cancer ; 40(7): 998-1005, 2004 May.
Article in English | MEDLINE | ID: mdl-15093574

ABSTRACT

To study the role of radiotherapy and tamoxifen after breast-conserving surgery (BCS) in patients with a favourable prognosis, a clinical trial was initiated by the German Breast Cancer Study Group. Between 1991 and 1998, 361 patients (pT1pN0M0, aged 45-75 years, receptor positive, grade I-II) were randomised to radiotherapy (yes/no) and tamoxifen for 2 years (yes/no) in a 2x2 factorial design; the exclusion of seven centres (14 patients) left 347 patients in the analysis. After a median follow-up of 5.9 years, 77 events concerning event-free survival have been observed. Since a strong interactive effect between radiotherapy and tamoxifen has been established, the results are presented in terms of the treatment effects for all four treatment groups separately. Mainly due to the presence of local recurrences, the event rate was about three times higher in the group with BCS only than in the other three groups. No difference could be established between the four treatment groups for distant disease-free survival rates. It is concluded that even in patients with a favourable prognosis, the avoidance of radiotherapy and tamoxifen after BCS increases the rate of local recurrences substantially.


Subject(s)
Antineoplastic Agents, Hormonal/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Tamoxifen/therapeutic use , Aged , Breast Neoplasms/surgery , Combined Modality Therapy , Disease-Free Survival , Female , Follow-Up Studies , Humans , Mastectomy, Segmental/methods , Middle Aged , Treatment Outcome
16.
Anticancer Res ; 22(1A): 439-43, 2002.
Article in English | MEDLINE | ID: mdl-12017329

ABSTRACT

The aim of this study was to analyze the toxicity and response rate of capecitabine in patients with recurrent ovarian cancer resistant to platinum and paclitaxel. Fourteen patients were enrolled in this phase I/II protocoL Capecitabine was administered orally in a dose of 2500 mg/m2/24 hours. A single therapy cycle consisted of a 2-week treatment, followed by a 2-week treatment-free interval. Patients were eligible for response evaluation if they completed more than one cycle of capecitabine. Cessation of chemotherapy due to toxicity was necessary in two patients. Diarrhea and hand-foot syndrome were the most common side-effects. In twelve patients eligible for response, there was one complete responder (8.3%), two partial responders (16.7%) and no change in three patients (25.0%). Progression of disease occurred in six patients (50.0%). Capecitabine exhibits antitumoral activity in ovarian cancer resistant to platinum and paclitaxel and should be evaluated in further studies.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Neoplasm Recurrence, Local/drug therapy , Ovarian Neoplasms/drug therapy , Adult , Aged , Antimetabolites, Antineoplastic/adverse effects , Capecitabine , Deoxycytidine/adverse effects , Drug Resistance, Multiple , Female , Fluorouracil/analogs & derivatives , Humans , Middle Aged , Organoplatinum Compounds/pharmacology , Paclitaxel/pharmacology
17.
Int J Cancer ; 94(1): 89-96, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11668483

ABSTRACT

Here we describe the effects of novel benzoxazol-2-yl and benzimidazol-2-yl hydrazones derived from 2-pyridinecarbaldehyde and 2-acetylpyridine. The IC(50) values for inhibition of cell proliferation in KB-3-1, CCRF-CEM, Burkitt's lymphoma, HT-29, HeLa, ZR-75 and MEXF276L by most of the novel compounds are in the nanomolar range. In colony-forming assays with human tumor xenografts the compounds 2-actylpyridine benzoxazol-2-ylhydrazone (EPH52), 2-acetylpyridine benzoimidazol-2-ylhydrazone (EPH61) and 2-acetylpyridine 1-methylbenzoimidazol-2-ylhydrazone (EPH116) exhibited above-average inhibition of colon carcinoma (IC(50) = 1.3-4.56 nM); EPH52 and EPH116 also exhibited above-average inhibition of melanoma cells. As shown with human liver microsomes, EPH116 is only moderately metabolized. The compound inhibited the growth of human colon cancer xenografts in nude mice in a dose-dependent manner. Thiosemicarbazones derived from 2-formylpyridines have been shown to be inhibitors of ribonucleotide reductase (RR). The following results show that RR is not the target of the novel compounds: cells overexpressing the M2 subunit of RR and resistant to the RR inhibitor hydroxyurea are not cross-resistant to the novel compounds; inhibition of RR occurs at 6- to 73-fold higher drug concentrations than that of inhibition of cell proliferation; the pattern of cell cycle arrest in S phase induced by the RR inhibitor hydroxyurea is not observed after treatment with the novel compounds; and a COMPARE analysis with the related compounds 2-acetylpyrazine benzothiazol-2-ylhydrazone (EPH95) and 3-acetylisoquinoline benzoxazol-2-ylhydrazone (EPH136) showed that the pattern of these compounds is not related to any of the standard antitumor drugs. Therefore, these novel compounds show inhibition of colon cancers and exhibit a novel mechanism of action.


Subject(s)
Antineoplastic Agents/pharmacology , Hydrazones/pharmacology , Neoplasms, Experimental/drug therapy , Animals , Apoptosis/drug effects , Cell Cycle/drug effects , Colonic Neoplasms/drug therapy , Humans , KB Cells , Male , Mice , Mice, Nude
18.
Gynecol Oncol ; 83(2): 286-91, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11606086

ABSTRACT

OBJECTIVE: FIGO stage III ovarian cancer is further categorized according to the size of tumor, but not according to the organs affected. In this study we evaluated the outcome of patients with and without macroscopic bowel involvement in stage III ovarian cancer. METHODS: This retrospective study analyzed the outcome of 194 ovarian cancer patients with FIGO III with and without bowel involvement who were operated on in our institution between 1985 and 1994. RESULTS: The study demonstrated that maximum tumor reduction without remaining macroscopic cancer offered the best overall survival times in FIGO III ovarian cancer patients. However, whenever the bowel was involved, even maximum bowel resections did not prolong survival compared to patients with remaining tumor after surgery. CONCLUSIONS: This retrospective study demonstrated that bowel involvement in ovarian cancer had a bad prognosis and that survival in these patients could not substantially be prolonged when the affected parts of bowel were resected. To further substantiate these findings, future studies on advanced ovarian cancer should differentiate between patients with and without bowel involvement.


Subject(s)
Intestinal Neoplasms/secondary , Intestinal Neoplasms/surgery , Ovarian Neoplasms/surgery , Epithelial Cells/pathology , Female , Humans , Middle Aged , Neoplasm Staging , Ovarian Neoplasms/pathology , Retrospective Studies , Survival Rate , Treatment Outcome
19.
J Cancer Res Clin Oncol ; 127(8): 495-501, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11501749

ABSTRACT

PURPOSE: In this study the effect of continuous stimulation of gonadotropins on sex cord stromal tumors in the rat was examined. METHODS: Sex cord stromal tumors were induced by transplantation of ovaries under the splenic capsule of ovariectomized rats. Beginning 180 days after transplantation, these tumors were taken out and cut into several pieces, which were then retransplanted (by isotransplantation) under the splenic capsule of 80 either intact or ovariectomized rats. RESULTS: Most of the tumor grafts grew up to a median size of 0.7 cm in ovariectomized rats. However, some of the tumors recovered from recipient rats that were retransplanted with donor tumors differed significantly from the others. Characterized by a high mitotic rate, nuclear atypia, size (up to 3.8 cm) as well as growth in intact animals, these tumors were defined as malignant. They could be kept in culture and always led to the development of metastases after retransplantation into other rats. CONCLUSION: Benign sex cord stromal tumors can show malignant growth after transplantation. This study for the first time demonstrates that gonadotropins are involved in the induction of ovarian malignancies.


Subject(s)
Gonadotropins/metabolism , Ovarian Neoplasms/pathology , Ovary/transplantation , Sex Cord-Gonadal Stromal Tumors/pathology , Animals , Cell Transformation, Neoplastic , Disease Progression , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Ovarian Neoplasms/metabolism , Ovariectomy , Rats , Sex Cord-Gonadal Stromal Tumors/metabolism , Time Factors , Transplantation, Autologous , Transplantation, Isogeneic
20.
Anticancer Res ; 21(3B): 2005-10, 2001.
Article in English | MEDLINE | ID: mdl-11497290

ABSTRACT

BACKGROUND: Despite a substantial body of epidemiological evidence, there is only a limited indication that gonadotropins and steroids have growth regulating functions in ovarian cancer. To elucidate the role of gonadotropins in regulating steroid metabolism in human ovarian cancer, we analyzed the modulation of estradiol secretion by FSH and hCG and the gonadotropic regulation of hCG secretion in vitro. Furthermore, we analyzed estradiol and hCG levels in serum and cyst fluids of patients with ovarian cancer. MATERIALS AND METHODS: OVCAR3 cells were incubated with estradiol (1, 5, 10 nM), FSH (100 microg/L) and hCG (10, 25 microg/L). Growth stimulation was evaluated by MTT assay. Estradiol was measured in the supernatant after incubation with hCG and FSH, while hCG was measured after FSH incubation. FSH, estradiol and hCG levels were measured in serum and cyst fluids of patients with ovarian cancer. RESULTS: OVCAR3 cells responded to hCG and FSH by increased estradiol secretion (p<0.001), while estradiol led to a dose-dependent stimulation of cell growth (p<0.05). 100 microg/L FSH led to a 75% decrease of hCG secretion (p<0.001). CONCLUSION: Gonadotropins stimulate estradiol secretion in ovarian cancer cells and modulate steroid dependent growth stimulation. FSH modulates hCG related growth stimulation in ovarian cancer. These results were supported by in vivo measurements in ovarian cancer patients.


Subject(s)
Gonadotropins/metabolism , Ovarian Neoplasms/drug therapy , Cell Division , Chorionic Gonadotropin/metabolism , Dose-Response Relationship, Drug , Female , Follicle Stimulating Hormone/metabolism , Humans , Ovarian Neoplasms/blood , Time Factors , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...